Invention Grant
US09320743B2 Use of 5α-androstane-3β,5,6β-triol in preparation of neuroprotective drugs
有权
使用5α-雄甾烷-3＆bgr; 5,6和bri-三醇制备神经保护药物
- Patent Title: Use of 5α-androstane-3β,5,6β-triol in preparation of neuroprotective drugs
- Patent Title (中): 使用5α-雄甾烷-3＆bgr; 5,6和bri-三醇制备神经保护药物
-
Application No.: US14332338Application Date: 2014-07-15
-
Publication No.: US09320743B2Publication Date: 2016-04-26
- Inventor: Guangmei Yan , Haiyan Hu , Tiandong Leng , Hanfei Sang , Jingxia Zhang , Pengxin Qiu , Shujia Zhou , Jiesi Chen , Xiuhua You
- Applicant: GUANGZHOU CELLPROTEK PHARMACEUTICAL LTD.
- Applicant Address: CN Guangzhou
- Assignee: GUANGZHOU CELLPROTEK PHARMACEUTICAL LTD.
- Current Assignee: GUANGZHOU CELLPROTEK PHARMACEUTICAL LTD.
- Current Assignee Address: CN Guangzhou
- Agency: Finnegan, Henderson, Farabow, Garrett & Dunner LLP
- Priority: CN201010224173 20100709
- Main IPC: A61K31/568
- IPC: A61K31/568 ; C07J1/00
Abstract:
Disclosed is the use of 5α-androstane-3β,5,6β-triol in preparing neuroprotective drugs. The compound has significant protective effect against neuron injuries caused by cerebral ischemia, spinal cord ischemia or hypoxia and has no obvious toxic reaction within effective dose thereof.
Public/Granted literature
- US20140329790A1 USE OF 5 alpha-ANDROSTANE-3 beta,5,6 beta-TRIOL IN PREPARATION OF NEUROPROTECTIVE DRUGS Public/Granted day:2014-11-06
Information query
